Carpenter Technology Corporation
CRS
$408.12
+0.35%
Carpenter Technology Corporation is a specialty metals producer that manufactures and distributes high-performance alloy and stainless steel products — including nickel-, cobalt-, and titanium-based alloys — serving aerospace and defense, medical, energy, transportation, industrial, and distribution end markets through its Specialty Alloys Operations (SAO) and Performance Engineered Products segments. The company occupies a differentiated niche in the steel industry as a premium, mission-critical materials supplier rather than a commodity producer, with its Reading and Latrobe, Pennsylvania mills and additional South Carolina and Alabama operations anchoring a vertically integrated domestic manufacturing footprint. The current investor narrative centers on an extraordinary aerospace-driven margin transformation: quarterly revenue reached $811.5 million in the March 2026 quarter with net income of $139.6 million, and the stock has rallied 82.2% over the past year as the market re-rated the business from a cyclical steel name into a high-margin aerospace supply-chain compounder. That enthusiasm has cooled sharply in recent months, however, with the shares down 16.2% over the past month and 21.1% over three months as investors debate whether the aerospace upcycle's best margin gains are already priced in and whether the stock's premium multiple can be sustained.…
CRS
Carpenter Technology Corporation
$408.12
Related headlines
Investment Opinion: Should I buy CRS Today?
The synthesized recommendation is Hold, with a bias toward accumulating on weakness. The core thesis is that Carpenter Technology has executed a genuine margin transformation — net margin expanded 460 basis points year-over-year to 17.2% in the March 2026 quarter — and the analyst consensus is unanimously positive with an average target of $625.88, implying 41.2% upside from the current $443.19. However, the stock trades at a significant premium to both its own history and the broader steel sector, and the recent 21.1% three-month decline suggests the market is questioning whether the aerospace upcycle's best margin gains are already priced in.
The supporting evidence is mixed but leans positive on fundamentals. Revenue grew 11.62% year-over-year to $811.5 million in the March 2026 quarter, with aerospace and defense contributing $534.2 million (roughly 66% of total). Gross margin expanded from 27.6% to 31.0%, operating margin from 19.0% to 23.0%, and net income reached $139.6 million. The balance sheet is conservative with debt-to-equity of 0.31 and a current ratio of 3.81, and trailing free cash flow is $407.4 million. However, the valuation is stretched: price-to-book of 13.85x and price-to-sales of 9.87x are roughly 4-5x typical steel-industry levels, and EV/EBITDA of 37.0x is more characteristic of a high-growth technology company. The forward PE of 27.9x versus trailing PE of 58.2x implies the market expects earnings to roughly double, which is a high bar.
The biggest risks that could invalidate the thesis are: (1) margin normalization if the 31.0% gross margin proves cyclical rather than structural, (2) aerospace demand deceleration given the 66% revenue concentration, and (3) multiple compression from the current premium levels. The rating would upgrade to Buy if the stock pulls back to the $380-$400 range (implying a forward PE near 18x) or if the next earnings report shows continued margin expansion above 31%. It would downgrade to Sell if gross margin falls below 28% or if aerospace revenue declines sequentially. On balance, the stock is fairly valued to slightly overvalued relative to its history and peers, but the growth trajectory and analyst support justify holding for investors already positioned, while new investors may find better entry points on further weakness.
Sign up to view all
CRS 12-Month Price Forecast
The forward-looking view is cautiously neutral with a medium confidence level. The company's fundamentals are strong — revenue growth of 11.62%, net margin expansion of 460 basis points, and a conservative balance sheet with debt-to-equity of 0.31 — but the valuation at 13.85x book and 37.0x EV/EBITDA leaves little room for error. The analyst consensus is unanimously bullish with an average target of $625.88, yet the stock has fallen 21.1% over three months, suggesting the market is pricing in peak-cycle concerns that analysts have not yet reflected. The key tension is whether the current 31.0% gross margin is a new structural baseline or a cyclical peak; if margins hold, the forward PE of 27.9x is reasonable and the stock is undervalued, but if they normalize, the premium multiple is unsustainable. I would upgrade to bullish if the next earnings report shows gross margin above 31.5% and aerospace revenue growing sequentially, and downgrade to bearish if gross margin falls below 28% or if analysts begin trimming targets.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Carpenter Technology Corporation's 12-month outlook, with a consensus price target around $625.88 and implied upside of +53.4% versus the current price.
Average Target
$625.88
0 analysts
Implied Upside
+53.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$540 - $700
Analyst target range
Carpenter Technology is covered by 8 analysts, and the consensus is decisively bullish. The average price target of $625.88 implies +41.2% upside from the current price of $443.19, with the low target of $540.00 still representing +21.8% upside and the high target of $700.00 implying +58.0% upside. Notably, the average target of $625.88 sits almost exactly at the 52-week high of $625.99, suggesting analysts view the recent pullback as a buying opportunity rather than a fundamental deterioration. The institutional ratings data reinforces this: every rating in the recent history is positive — JP Morgan (Overweight), TD Cowen (Buy), Susquehanna (Positive), KeyBanc (Overweight), BTIG (Buy), and Wells Fargo (Equal Weight) — with no downgrades and no sell ratings, indicating strong conviction that the aerospace-driven earnings trajectory remains intact. The target range of $540 to $700 is relatively tight (a 30% spread between low and high), which signals high analyst conviction and low dispersion of opinion — a notable contrast to the stock's recent 28.4% drawdown, which suggests the selloff is technical or sentiment-driven rather than fundamentally driven. The high target of $700 assumes continued aerospace demand strength, further margin expansion beyond the current 31% gross margin, and successful execution on growth capex that drives EPS toward or above the $23.56 high estimate; the low target of $540 assumes some margin normalization and slower aerospace build rates but still embeds a premium multiple. The consensus revenue estimate of $4.73 billion (range $4.52–$4.94 billion) and EPS estimate of $22.30 (range $21.04–$23.56) imply roughly 30%+ EPS growth, which at the forward PE of 27.9x would justify a share price in the $580–$660 range — consistent with the analyst targets. The key risk is that the stock has already fallen 21% over three months despite universally positive ratings, which may indicate that the market is pricing in something analysts are not yet reflecting, such as peak-cycle margin concerns or valuation compression; investors should watch whether analysts maintain these targets through the next earnings report or begin trimming them, as a downgrade cycle would be a significant negative signal given the stock's premium valuation.
Drowning in data?
Find the real signal!
Bulls vs Bears: CRS Investment Factors
The bull case currently has stronger evidence, anchored by a genuine margin transformation (net margin up 460 basis points year-over-year to 17.2%), a conservative balance sheet (debt-to-equity of 0.31), and unanimous positive analyst ratings with an average target of $625.88 implying 41.2% upside. However, the bear case is gaining traction: the stock has fallen 21.1% over three months despite no negative analyst actions, and the valuation is extreme at 13.85x book and 37.0x EV/EBITDA, roughly 4-5x sector norms. The single most important tension is whether the current 31.0% gross margin is a new structural baseline or a cyclical peak tied to the aerospace upcycle — if margins hold, the forward PE of 27.9x is reasonable and the stock is cheap; if they normalize toward 2024 levels, the premium multiple is unsustainable and the recent decline is the beginning of a deeper re-rating. The recent 28.4% peak-to-trough drawdown and negative short-term relative strength suggest the market is already voting on this question, and the next earnings report will likely be the decisive catalyst.
Bullish
- Aerospace-driven margin transformation: Gross margin expanded from 27.6% in the March 2025 quarter to 31.0% in the March 2026 quarter, while operating margin rose from 19.0% to 23.0% and net margin from 13.1% to 17.2%. This 460 basis point net margin expansion reflects a favorable mix shift toward high-value aerospace alloys, with aerospace and defense contributing $534.2 million, or roughly 66% of total revenue.
- Analyst consensus implies 41% upside: All 8 covering analysts have positive ratings (JP Morgan Overweight, TD Cowen Buy, Susquehanna Positive, KeyBanc Overweight, BTIG Buy, Wells Fargo Equal Weight), with an average target of $625.88 versus the current $443.19. Even the low target of $540.00 implies 21.8% upside, and the tight $540-$700 range signals high conviction and low dispersion.
- Earnings expected to roughly double: The forward PE of 27.9x versus trailing PE of 58.2x implies the market expects earnings to roughly double, corroborated by consensus EPS estimates of $22.30 (range $21.04-$23.56) versus trailing EPS of $0.017. At the forward multiple, $22.30 of EPS implies a share price near $622, almost exactly the 52-week high of $625.99.
- Conservative balance sheet, strong cash generation: Debt-to-equity is just 0.31, the current ratio is a healthy 3.81, and trailing free cash flow is $407.4 million. The company returned $52.7 million via buybacks and $10.1 million in dividends in the March 2026 quarter while growing cash to $294.8 million, and ROE of 23.8% and ROA of 11.9% are strong for a metals processor.
Bearish
- Extreme valuation premium to sector: Price-to-book of 13.85x and price-to-sales of 9.87x are roughly 4-5x typical steel-industry levels (most producers trade at 1-3x book and 0.5-2x sales), while EV/EBITDA of 37.0x and EV/Sales of 7.2x are more characteristic of a high-growth tech or aerospace supplier. The PEG ratio of 1.41 offers a more balanced view but still leaves little room for error.
- Momentum breakdown and relative underperformance: The stock is down 16.2% over the past month and 21.1% over three months, versus SPY's -1.06% and +3.04%, producing relative strength readings of -15.1 and -24.1 percentage points. This divergence between the +82.2% 1-year return and the -16.2% 1-month return is a textbook momentum breakdown that could signal distribution or early trend reversal.
- Aerospace concentration is a single point of failure: Aerospace and defense contributes $534.2 million, or roughly 66% of total revenue, dwarfing industrial and consumer ($97.0 million), energy ($69.0 million), medical ($65.8 million), transportation ($24.7 million), and distribution ($20.8 million). Any softening in commercial aerospace build rates or defense budgets would disproportionately impact the entire investment case.
- Margins may be cyclical peaks, not structural: The trailing gross margin of 30.6% and operating margin of 22.5% are exceptional for a metals processor, but the risk is that these margins are tied to an aerospace upcycle rather than a new structural baseline. A normalization toward the 24-26% gross margin range seen in 2024 would compress earnings and expose the premium multiple.
CRS Technical Analysis
Carpenter Technology is in a powerful longer-term uptrend that has recently entered a corrective phase. The stock is up 82.2% over the past year and 31.0% year-to-date, but at $443.19 it sits 29.2% below its 52-week high of $625.99 and 94.4% above its 52-week low of $228.00 — positioning it at roughly 54% of its 52-week range, squarely in the middle of the band rather than at either extreme. That mid-range positioning after a violent 28.4% peak-to-trough drawdown (max_drawdown of -28.43%) suggests the stock is neither an overextended momentum chase nor a deep-value falling knife, but rather a high-beta name digesting a parabolic advance. The 1-year relative strength versus SPY of +66.0 percentage points confirms that despite the recent pullback, CRS remains a decisive long-term market outperformer. Recent momentum has deteriorated sharply and now diverges violently from the longer-term trend. The stock is down 16.2% over the past month and 21.1% over three months, versus a 1-month SPY change of -1.06% and a 3-month SPY change of +3.04% — producing relative strength readings of -15.1 and -24.1 percentage points over those windows. This is a textbook momentum breakdown: the 6-month change remains positive at +22.7% and the 1-year change is +82.2%, so the intermediate-term trend is still up, but the short-term trend has turned decisively negative, signaling distribution and possible mean reversion toward longer-term support. The divergence between the +82.2% 1-year return and the -16.2% 1-month return is the key technical tension — either a healthy pullback within a secular uptrend or the early stage of a trend reversal, and the next few weeks of price action will likely resolve it. Key technical levels are well defined by the 52-week range. Support sits near the $228.00 52-week low, with intermediate support likely in the $440–$460 zone where the stock is currently consolidating; a decisive breakdown below $440 would open the door to a retest of the $400 area and potentially the mid-$300s. Resistance is anchored at the $625.99 52-week high, with the $500–$520 zone acting as the first major hurdle — a breakout above $520 would signal the correction has run its course, while a failure there would confirm the downtrend. With a beta of 1.261, CRS is roughly 26% more volatile than the market, meaning position sizing should be scaled down accordingly; the 2.02 short ratio indicates short interest is moderate and not yet a contrarian squeeze catalyst, while daily volume of roughly 403,173 shares suggests liquidity is adequate but not deep, which can amplify moves in either direction.
Beta
1.26
1.26x market volatility
Max Drawdown
-34.3%
Largest decline past year
52-Week Range
$228-$626
Price range past year
Annual Return
+65.4%
Cumulative gain past year
| Period | CRS Return | S&P 500 |
|---|---|---|
| 1m | -20.0% | -1.0% |
| 3m | -30.4% | +2.0% |
| 6m | +12.6% | +17.4% |
| 1y | +65.4% | +15.0% |
| ytd | +20.6% | +11.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CRS Fundamental Analysis
Carpenter Technology's revenue trajectory is one of accelerating growth driven overwhelmingly by aerospace. The most recent quarter (period ending 2026-03-31) delivered revenue of $811.5 million, up 11.62% year-over-year, following $728.0 million in the December 2025 quarter (+7.5% YoY versus $676.9 million) and $733.7 million in the September 2025 quarter (+2.2% YoY versus $717.6 million). The sequential and YoY acceleration is striking: revenue rose from $727.0 million in the March 2025 quarter to $811.5 million in the March 2026 quarter, and the segment data shows aerospace and defense markets contributing $534.2 million — roughly 66% of total revenue — dwarfing industrial and consumer ($97.0 million), energy ($69.0 million), medical ($65.8 million), transportation ($24.7 million), and distribution ($20.8 million). This concentration in aerospace is the engine of the investment case, but it also represents a single-point-of-failure risk if commercial aerospace build rates or defense budgets soften. Profitability has expanded dramatically and is now best-in-class for the specialty steel industry. Net income reached $139.6 million in the March 2026 quarter on a 17.2% net margin, up from $95.4 million and a 13.1% net margin in the year-ago quarter — a 460 basis point margin expansion. Gross margin has climbed steadily from 27.6% (March 2025) to 31.0% (March 2026), while operating margin expanded from 19.0% to 23.0% over the same period, and EBITDA margin improved from 23.9% to 27.4%. The company's trailing gross margin of 30.6% and operating margin of 22.5% are exceptional for a metals processor, reflecting a favorable mix shift toward higher-value aerospace alloys and improved pricing power; the risk is that these margins are cyclical peaks tied to an aerospace upcycle rather than a new structural baseline. The balance sheet is conservatively positioned with strong cash generation. Debt-to-equity stands at just 0.31, the current ratio is a healthy 3.81, and trailing free cash flow is $407.4 million — a 1.3% FCF yield on the $30.8 billion market cap, which is modest but reflects heavy growth capex ($68.7 million in the March 2026 quarter alone). ROE of 23.8% and ROA of 11.9% are strong, and the company returned capital via $52.7 million of buybacks and $10.1 million of dividends in the quarter while still growing cash to $294.8 million. The main caveat is the elevated price-to-free-cash-flow ratio of 51.0x and EV/EBITDA of 37.0x, which imply the market is capitalizing current cash flows at a very rich rate; the company's ability to convert its aerospace-driven earnings into durable free cash flow as capex normalizes will be critical to justifying the valuation.
Quarterly Revenue
$811500000.0B
2026-03
Revenue YoY Growth
+11.6%
YoY Comparison
Gross Margin
31.0%
Latest Quarter
Free Cash Flow
$407400000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CRS Overvalued?
Because Carpenter Technology is solidly profitable — trailing net income is positive and the March 2026 quarter alone generated $139.6 million — the PE ratio is the appropriate primary valuation metric. The stock trades at a trailing PE of 58.2x versus a forward PE of 27.9x, a dramatic 52% compression that implies the market expects earnings to roughly double over the next twelve months. That expectation is corroborated by analyst EPS estimates: the consensus forward EPS of $22.30 compares to the current trailing EPS of just $0.017 (a data artifact reflecting a near-zero trailing figure), and the forward PE of 27.9x on $22.30 of estimated EPS implies a share price near $622 — remarkably close to the 52-week high of $625.99, suggesting the market has already priced in the forward earnings recovery. The gap between trailing and forward multiples is the single most important valuation signal here: it tells investors that the bull case rests entirely on earnings delivery, and any miss would leave the stock looking extremely expensive on trailing numbers. Relative to the broader steel and basic materials sector, CRS trades at a substantial premium across every metric. The price-to-book ratio of 13.85x and price-to-sales ratio of 9.87x are far above typical steel-industry levels (most integrated and specialty steel producers trade between 1x and 3x book and 0.5x to 2x sales), while EV/EBITDA of 37.0x and EV/Sales of 7.2x are multiples more characteristic of a high-growth technology or aerospace supplier than a metals processor. The premium is partially justified by CRS's 30.6% gross margin, 17.0% net margin, and 23.8% ROE — all far above commodity steel peers — but the magnitude of the premium (roughly 4–5x the sector on book value) leaves little room for error. The PEG ratio of 1.41 offers a more balanced view, suggesting the valuation is roughly in line with the company's growth rate when adjusted for earnings expansion. Historically, CRS is trading near the very top of its own valuation band. The trailing PE of 58.2x compares to a historical range that has oscillated between roughly 14x (June 2024) and 150x (March 2024, during an earnings trough), with the current reading in the upper quartile; more tellingly, the price-to-sales ratio of 9.87x is nearly double the 5.2x–6.7x range seen in 2023–2024 and the price-to-book of 13.85x is roughly 4x the 3.3x–4.8x levels of mid-2024. The historical ratios data shows a clear re-rating from a ~2.4x book / ~5x sales valuation in 2023 to today's 13.8x book / 9.9x sales, reflecting the market's recognition of the margin transformation — but also meaning the stock now embeds highly optimistic expectations. At these levels, the valuation is vulnerable to any deceleration in aerospace demand or margin normalization, and the recent 21% three-month decline may be the market beginning to question whether the re-rating has overshot.
PE
58.2x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 14x~37x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
37.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on the sustainability of current margins and the concentration of revenue in a single end market. Aerospace and defense accounts for $534.2 million, or roughly 66% of total revenue, meaning any deceleration in commercial build rates or defense spending would disproportionately impact results. The trailing gross margin of 30.6% and operating margin of 22.5% are exceptional for a metals processor, but they may represent cyclical peaks; a normalization toward the 24-26% gross margin range seen in 2024 would compress net income materially. Additionally, the price-to-free-cash-flow ratio of 51.0x and a modest 1.3% FCF yield mean the company must convert earnings into durable free cash flow as growth capex ($68.7 million in the March 2026 quarter) normalizes, or the valuation will be difficult to justify. Debt-to-equity of 0.31 and a current ratio of 3.81 provide a cushion, but the company remains exposed to input cost inflation and energy prices given its energy-intensive melting operations.
Market and competitive risks are dominated by valuation compression and the stock's high beta. At 13.85x book and 9.87x sales, CRS trades at roughly 4-5x typical steel-industry multiples, leaving little room for error; any deceleration in aerospace demand or margin normalization could trigger a sharp de-rating. The beta of 1.261 means the stock is roughly 26% more volatile than the market, so a broad market selloff would hit CRS disproportionately. Competitive threats include alternative materials and processes, as well as capacity additions from peers such as ATI and Allegheny Technologies in the specialty alloy space, which could pressure pricing. The recent 21.1% three-month decline despite universally positive analyst ratings suggests the market may be pricing in peak-cycle concerns or valuation compression that analysts have not yet reflected, and a downgrade cycle would be a significant negative signal given the premium valuation.
In a worst-case scenario, a combination of aerospace order deferrals, margin normalization toward 2024 levels, and multiple compression could drive the stock toward its 52-week low of $228.00, representing a 48.5% decline from the current $443.19. The analyst low target of $540.00 still implies 21.8% upside, so even the bear case among analysts is not deeply negative, but the stock's own 52-week low and the 28.4% max drawdown show how quickly sentiment can reverse. A realistic adverse scenario might see the stock retest the $400 area (a 9.7% decline) and potentially the mid-$300s (a 20-25% decline) if the next earnings report shows margin compression or slowing aerospace orders. From the current price, an investor could lose 20-25% in a moderate bear case and up to 48% in a severe scenario that takes the stock back to its 52-week low.
FAQ
The most severe risk is aerospace concentration, with 66% of revenue ($534.2 million) coming from aerospace and defense; any build-rate cuts or defense budget reductions would disproportionately impact results. Second is margin sustainability: the current 31.0% gross margin and 17.2% net margin may be cyclical peaks, and a normalization toward 2024 levels (24-26% gross margin) would compress earnings and expose the premium multiple. Third is valuation compression: at 13.85x book and 37.0x EV/EBITDA, the stock trades at roughly 4-5x sector norms, leaving little room for error, and the 1.261 beta means a broad market selloff would hit CRS disproportionately. Fourth is competitive pressure from peers like ATI in the specialty alloy space, which could pressure pricing. Ranked by severity: aerospace concentration, margin sustainability, valuation compression, and competition.
The 12-month forecast has three scenarios. The base case (50% probability) targets $540-$626, assuming revenue grows 10-12%, gross margin holds at 30-31%, and EPS reaches the $22.30 consensus, consistent with the analyst average target of $625.88. The bull case (30% probability) targets $625-$700, requiring margin expansion beyond 31.5% and EPS toward the high estimate of $23.56, supported by continued aerospace demand and successful capex execution. The bear case (20% probability) targets $228-$400, driven by aerospace order deferrals, margin normalization, and multiple compression, with a severe case retesting the 52-week low of $228.00. The base case is most likely, with the key assumption being that the aerospace upcycle continues at a moderating pace and current margins prove structural rather than cyclical.
CRS appears overvalued on trailing metrics but fairly valued on forward estimates. The trailing PE of 58.2x and price-to-book of 13.85x are far above typical steel-industry levels (most producers trade at 1-3x book), and the price-to-sales of 9.87x is roughly double the 5.2x-6.7x range seen in 2023-2024. However, the forward PE of 27.9x on consensus EPS of $22.30 implies a share price near $622, almost exactly the 52-week high of $625.99, suggesting the market has already priced in the forward earnings recovery. The PEG ratio of 1.41 offers a more balanced view, indicating the valuation is roughly in line with the growth rate. The market is paying a premium for the margin transformation, and the key question is whether the current 31.0% gross margin is sustainable. If it is, the stock is fairly valued; if not, it is significantly overvalued.
From a risk/reward perspective, CRS presents a balanced proposition. The analyst consensus target of $625.88 implies 41.2% upside from the current $443.19, and all 8 covering analysts have positive ratings, which is a strong vote of confidence. However, the stock trades at a premium valuation (13.85x book, 37.0x EV/EBITDA) and has fallen 21.1% over three months despite those ratings, suggesting the market is pricing in risks that analysts may be underestimating. The biggest downside risk is margin normalization toward 2024 levels, which could drive the stock toward $400 or lower. For investors with a 12-24 month horizon and tolerance for volatility (beta of 1.261), the risk/reward is favorable if the aerospace upcycle continues, but position sizing should be scaled down accordingly. It is a good buy for growth-oriented investors who believe the margin transformation is structural, but not for those seeking value or income.
CRS is better suited for long-term investment with a minimum holding period of 12-24 months, given the company's growth stage and the cyclical nature of its end markets. The stock's beta of 1.261 means it is roughly 26% more volatile than the market, and the recent 28.4% max drawdown and 21.1% three-month decline illustrate the risks of short-term trading. The dividend yield is negligible at 0.13% with a payout ratio of 7.6%, so income is not a reason to hold. Earnings visibility is moderate — the aerospace upcycle provides a multi-year tailwind, but quarterly results can be volatile. Short-term traders could exploit the high beta and defined technical levels ($440 support, $520 resistance), but the risk of sharp drawdowns is significant. For most investors, a long-term horizon of at least 12-24 months is appropriate to ride out the cyclicality and allow the margin transformation to prove itself.
